Dutch Cabinet Supports Construction Of PALLAS Research Reactor The Dutch Minister of Health, Welfare and Sport Ernst Kuipers recently announced, that money has been set aside for the construction of the PALLAS reactor in Petten, North Holland, in the coming years. The ministry is reserving 30 million euros for the project this year and 129…
NRG And Curium Sign Contract For Production of Mo-99 NRG (ENS Corporate Member) and Curium have signed a multi-year contract for the production of molybdenum-99, the starting material for technetium-99m (Tc-99m). Tc-99m is the most used isotope in nuclear medicine for diagnosing life-threatening diseases, such as cardiovascular diseases, lung and brain disorders and cancer. With…
NRG Starts Irradiating Nuclear Reactor Containment Tubes For EDF In December 2020 EDF (Électricité de France) and NRG (both ENS Corporate Members) have started a cooperation on the irradiation of containment tubes. The purpose of the irradiation is to gain knowledge on the behavior of containment tubes under operating conditions that are to be considered…
NRG Safety Committee Approved Restart Solution For HFR In Petten The High-Flux Reactor (HFR) in Petten, Netherlands, did not start up on 20 January 2022, due to a leak in a water system. NRG (ENS Corporate Member) reported no risk to nuclear safety, man, or the environment. Since the discovery of the technical failure in…
HFR 60th Anniversary And The Rising Demand For Radiopharmaceuticals The demand for medical treatments is rising sharply, partly due to the increased incidence of cancer. In the past year, 115,000 new cases of cancer have been diagnosed in the Netherlands, 13,000 of which prostate cancer. Consequently, NRG|PALLAS is seeing an increase in the demand for…
NRG to Start Fuel Qualification Program for USNC Micro Modular Reactor Ultra Safe Nuclear Corporation (USNC) announces that it has begun working with the Nuclear Research & Consultancy Group (NRG) from the Netherlands. NRG will implement a program to analyze performance and safety attributes of the company’s proprietary Fully Ceramic Microencapsulated (FCMTM) fuel designed for…
Petten HFR Will Produce Medical Isotopes Only With LEU The High Flux Reactor in Petten, operated by NRG, from now on produces only medical isotopes with low-enriched uranium (LEU). Until recently, the productions for NRG’s Belgian partner IRE were still based on high-enriched uranium, because IRE could not fully process low-enriched uranium. But now IRE…
NRG delivers 10 patient doses of Lutetium-177 Last week, NRG has delivered lutetium for the first time to an academic hospital and two pharmaceutical parties this month. Sander de Groot, program manager medical isotopes at NRG: “This isotope offers a great perspective for the effective treatment of various cancer indications and with limited side effects.…
NRG And PALLAS Together For A Shared, Innovative Future NRG and PALLAS aim to fuse together as one organisation, as announced by Bertholt Leeftink, CEO NRG/PALLAS. “By combining our forces, we are able to make large steps forward in the development and production of nuclear medicines used for diagnostic purposes and for the treatment of…
NRG And Terrestrial Energy Start Graphite Irradiation Testing For IMSR ENS Corporate Member Nuclear Research and Consultancy Group (NRG) and Terrestrial Energy have started a graphite irradiation testing programme for the Integral Molten Salt Reactor power plant at NRG’s high flux research reactor (HFR) at Petten in the Netherlands. The work is part of a…